Earnings Call · Q4 FY2025·2026-02-04

Q4 25EPS +2.26%·Rev n/aQ3 25EPS +4.49%·Rev n/aQ2 25EPS +2.06%·Rev n/aQ1 25EPS +2.50%·Rev n/a⚠ consensus missing

AbbVie Inc. ABBV

Elizabeth Shea — Vice President, Investor Relations

Robert Michael — Chairman and Chief Executive Officer

Jeffrey Stewart — Executive Vice President, Chief Commercial Officer

Roopal Thakkar — Executive Vice President, Research and Development, Chief Scientific Officer

Scott Reents — Executive Vice President, Chief Financial Officer

−3.8%1d on move date−3.3% vs SPY3d−1.0%5d−1.4%

Research tier

Behavioral profile computed for 5 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more ABBV calls or request research access.

More ABBV calls Browse calls Request research access